Analysts Viewpoint
Hoth Therapeutics Inc (HOTH) gets rating Initiated from The Benchmark Company
Hoth Therapeutics Inc’s filing revealed that its CEO and President Knie Robb acquired Company’s shares for reported $16750.0 on Aug
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.